The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
269
ONE-YEAR COMPARATIVE EFFECTIVENESS AND SAFETY OF UPADACITINIB VERSUS RISANKIZUMAB FOR CROHN’S DISEASE
Date
May 3, 2025
Explore related products in the following collection:
